负载GOLPH3 siRNA的阳离子脂质体抑制胶质瘤生长
本研究探讨GOLPH3作为胶质瘤基因治疗靶点的可行性,采用偶联angiopep-2的阳离子脂质体(A2-CL)递送siGOLPH3跨越血脑屏障到达胶质瘤;细胞水平上A2-CL/siGOLPH3可沉默GOLPH3并有效抑制细胞增殖;体内实验采用U87-GFP-Luci荷瘤BALB/c小鼠模型,证明A2-CL可将GOLPH3-siRNA特异性递送至胶质瘤并有效抑制胶质瘤生长。
要点
- A2-CL/siGOLPH3在细胞水平可沉默GOLPH3并有效抑制细胞增殖。
- 在U87-GFP-Luci荷瘤BALB/c小鼠模型中,A2-CL可将GOLPH3-siRNA特异性递送至胶质瘤。
- 体内实验显示A2-CL/siGOLPH3可有效抑制胶质瘤生长。
核心结论
- 本研究表明GOLPH3作为胶质瘤基因治疗靶点具有很大潜力,在精准医疗应用中具有重要价值。
研究设计与样本
- 研究采用偶联angiopep-2的阳离子脂质体(A2-CL)递送siGOLPH3,以跨越血脑屏障并到达胶质瘤。
- 细胞水平实验评估A2-CL/siGOLPH3对GOLPH3的沉默作用及对细胞增殖的影响。
- 体内实验采用U87-GFP-Luci荷瘤BALB/c小鼠模型,评估A2-CL递送GOLPH3-siRNA至胶质瘤的靶向性及对胶质瘤生长的抑制作用。
主要发现
- 细胞水平上,A2-CL/siGOLPH3可沉默GOLPH3,并随后有效抑制细胞增殖。
- 体内实验中,A2-CL可将GOLPH3-siRNA特异性递送至胶质瘤,并有效抑制胶质瘤生长。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: GOLPH3 has been shown to be involved in glioma proliferation. In this study, we aimed to demonstrate that GOLPH3 can serve as a target for glioma gene therapy. METHODS: During the experiment, cationic liposomes with angiopep-2 (A2-CL) were used to deliver siGOLPH3 crossing the blood-brain barrier and reaching the glioma. RESULTS: At the cellular level, the A2-CL/siGOLPH3 could silence GOLPH3 and then effectively inhibited the proliferation of cells. In vivo experiments, using U87-GFP-Luci-bearing BALB/c mouse models, we demonstrated that A2-CL could deliver GOLPH3-siRNA specifically to glioma and effectively inhibit glioma growth. CONCLUSIONS: This study shows that GOLPH3 has great potential as a target for the gene therapy of glioma and is of great value in precise medical applications.
引用
- Yuan Z, Zhao L, Zhang Y, et al. Inhibition of glioma growth by a GOLPH3 siRNA-loaded cationic liposomes. J Neurooncol. 2018. PMID: 30105446. doi:10.1007/s11060-018-2966-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。